Alpha Tau Medical (DRTS) News Today $2.32 +0.02 (+0.87%) (As of 11/22/2024 ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period Alpha Tau Medical (NASDAQ:DRTS) Receives Buy Rating from HC WainwrightHC Wainwright reaffirmed a "buy" rating and set a $9.00 price objective on shares of Alpha Tau Medical in a research report on Friday.November 22 at 8:18 AM | marketbeat.comAlpha Tau transferred with Buy rating at CitiNovember 15, 2024 | markets.businessinsider.comAlpha Tau Medical Ltd: A Unique Player in Radiopharmaceuticals with Promising Advances in Alpha DaRT TechnologyNovember 15, 2024 | markets.businessinsider.comShort Interest in Alpha Tau Medical Ltd. (NASDAQ:DRTS) Grows By 30.5%Alpha Tau Medical Ltd. (NASDAQ:DRTS - Get Free Report) was the recipient of a large growth in short interest during the month of October. As of October 31st, there was short interest totalling 67,100 shares, a growth of 30.5% from the October 15th total of 51,400 shares. Based on an average daily volume of 22,200 shares, the days-to-cover ratio is currently 3.0 days. Approximately 0.1% of the company's stock are short sold.November 15, 2024 | marketbeat.comAlpha Tau to Participate in Citi's 2024 Global Healthcare Conference and Piper Sandler's 36th Annual Healthcare ConferenceNovember 13, 2024 | globenewswire.comAlpha Tau Medical (NASDAQ:DRTS) Receives "Buy" Rating from HC WainwrightHC Wainwright reiterated a "buy" rating and set a $9.00 price objective on shares of Alpha Tau Medical in a report on Wednesday.October 23, 2024 | marketbeat.comAlpha Tau announces acceptance into FDA’s TPLC TAP PilotOctober 22, 2024 | markets.businessinsider.comAlpha Tau Announces Acceptance Into FDA's Total Product Life Cycle Advisory Program to Accelerate Market Access to Alpha DaRT® for Patients with Recurrent Glioblastoma MultiformeOctober 21, 2024 | globenewswire.comAlpha Tau Medical Ltd. (NASDAQ:DRTS) Short Interest UpdateAlpha Tau Medical Ltd. (NASDAQ:DRTS - Get Free Report) was the target of a large growth in short interest in September. As of September 30th, there was short interest totalling 43,600 shares, a growth of 6.6% from the September 15th total of 40,900 shares. Based on an average daily trading volume, of 25,200 shares, the short-interest ratio is presently 1.7 days. Approximately 0.1% of the shares of the stock are sold short.October 16, 2024 | marketbeat.comAlpha Tau Medical's (DRTS) "Buy" Rating Reaffirmed at HC WainwrightHC Wainwright restated a "buy" rating and issued a $9.00 price objective on shares of Alpha Tau Medical in a research report on Friday.October 11, 2024 | marketbeat.comAlpha Tau Treats First Patient with Recurrent Lung CancerOctober 10, 2024 | globenewswire.comFDA approves study of Alpha Tau’s Alpha DaRT for recurrent cSCC treatmentSeptember 23, 2024 | msn.comAlpha Tau Announces FDA Approval of IDE to Initiate Multi-Center Investigator-Initiated Study of Alpha DaRT® in Immunocompromised Patients with Recurrent cSCCSeptember 20, 2024 | globenewswire.comAlpha Tau Medical Ltd. (NASDAQ:DRTS) Short Interest Up 63.4% in AugustAlpha Tau Medical Ltd. (NASDAQ:DRTS - Get Free Report) saw a large increase in short interest during the month of August. As of August 31st, there was short interest totalling 33,000 shares, an increase of 63.4% from the August 15th total of 20,200 shares. Approximately 0.1% of the shares of the company are short sold. Based on an average daily trading volume, of 33,200 shares, the short-interest ratio is presently 1.0 days.September 13, 2024 | marketbeat.comAlpha Tau to Participate in the H.C. Wainwright 26th Annual Global Investment Conference, the Sidoti Small-Cap Virtual Investor Conference, the Redburn Atlantic and Rothschild & Co 2024 Radiopharma Conference, and the Lytham Partners Fall 2024 Investor ConferenceAugust 22, 2024 | globenewswire.comAlpha Tau Medical Ltd. to Post FY2024 Earnings of ($0.47) Per Share, HC Wainwright Forecasts (NASDAQ:DRTS)Alpha Tau Medical Ltd. (NASDAQ:DRTS - Free Report) - Research analysts at HC Wainwright reduced their FY2024 EPS estimates for shares of Alpha Tau Medical in a report issued on Tuesday, August 20th. HC Wainwright analyst Y. Chen now forecasts that the company will earn ($0.47) per share for the yAugust 22, 2024 | marketbeat.comAlpha Tau Medical's (DRTS) "Buy" Rating Reiterated at HC WainwrightHC Wainwright reaffirmed a "buy" rating and issued a $9.00 target price on shares of Alpha Tau Medical in a research report on Tuesday.August 20, 2024 | marketbeat.comAlpha Tau Medical Ltd.: Alpha Tau Medical Announces Second Quarter 2024 Financial Results and Provides Corporate UpdateAugust 16, 2024 | finanznachrichten.dePiper Sandler Reaffirms Their Buy Rating on Alpha Tau Medical Ltd (DRTS)August 16, 2024 | markets.businessinsider.comAlpha Tau Medical (NASDAQ:DRTS) Stock Rating Reaffirmed by Piper SandlerPiper Sandler reiterated an "overweight" rating and set a $7.00 price target on shares of Alpha Tau Medical in a research report on Thursday.August 15, 2024 | marketbeat.comAlpha Tau Medical Announces Second Quarter 2024 Financial Results and Provides Corporate UpdateAugust 14, 2024 | globenewswire.comShort Interest in Alpha Tau Medical Ltd. (NASDAQ:DRTS) Grows By 60.8%Alpha Tau Medical Ltd. (NASDAQ:DRTS - Get Free Report) was the recipient of a significant growth in short interest in June. As of June 30th, there was short interest totalling 28,300 shares, a growth of 60.8% from the June 15th total of 17,600 shares. Based on an average daily volume of 41,300 shares, the days-to-cover ratio is currently 0.7 days. Approximately 0.1% of the shares of the stock are sold short.July 12, 2024 | marketbeat.comAlpha Tau Announces Publication in Cancers Journal of Long-Term Safety and Efficacy Data in Multiple Hard-to-Treat Superficial CancersJune 25, 2024 | globenewswire.comAlpha Tau Medical Ltd. (NASDAQ:DRTS) Sees Large Drop in Short InterestAlpha Tau Medical Ltd. (NASDAQ:DRTS - Get Free Report) saw a large decline in short interest in May. As of May 15th, there was short interest totalling 26,900 shares, a decline of 6.9% from the April 30th total of 28,900 shares. Approximately 0.1% of the company's stock are sold short. Based on an average trading volume of 34,800 shares, the short-interest ratio is currently 0.8 days.June 4, 2024 | marketbeat.comFY2024 EPS Estimates for Alpha Tau Medical Ltd. Raised by HC Wainwright (NASDAQ:DRTS)Alpha Tau Medical Ltd. (NASDAQ:DRTS - Free Report) - Research analysts at HC Wainwright raised their FY2024 earnings estimates for shares of Alpha Tau Medical in a research note issued on Wednesday, May 22nd. HC Wainwright analyst Y. Chen now forecasts that the company will post earnings per sharMay 24, 2024 | marketbeat.comAlpha Tau Medical Ltd. (NASDAQ:DRTS) to Post Q2 2025 Earnings of ($0.13) Per Share, HC Wainwright ForecastsAlpha Tau Medical Ltd. (NASDAQ:DRTS - Free Report) - Equities research analysts at HC Wainwright issued their Q2 2025 earnings per share estimates for shares of Alpha Tau Medical in a research report issued on Wednesday, May 22nd. HC Wainwright analyst Y. Chen anticipates that the company will poMay 23, 2024 | marketbeat.comAlpha Tau Medical (NASDAQ:DRTS) Stock Rating Reaffirmed by HC WainwrightHC Wainwright reissued a "buy" rating and issued a $9.00 price target on shares of Alpha Tau Medical in a report on Wednesday.May 22, 2024 | marketbeat.comPiper Sandler Keeps Their Buy Rating on Alpha Tau Medical Ltd (DRTS)May 21, 2024 | markets.businessinsider.comAlpha Tau Medical (NASDAQ:DRTS) Posts Quarterly Earnings Results, Beats Estimates By $0.02 EPSAlpha Tau Medical (NASDAQ:DRTS - Get Free Report) posted its quarterly earnings data on Monday. The company reported ($0.11) EPS for the quarter, beating the consensus estimate of ($0.13) by $0.02.May 21, 2024 | marketbeat.comAlpha Tau to Present at the Jefferies Global Healthcare ConferenceMay 21, 2024 | globenewswire.comAlpha Tau Medical Ltd.: Alpha Tau Medical Announces First Quarter 2024 Financial Results and Provides Corporate UpdateMay 21, 2024 | finanznachrichten.deAlpha Tau Medical Announces First Quarter 2024 Financial Results and Provides Corporate UpdateMay 20, 2024 | globenewswire.comAlpha Tau Medical (NASDAQ:DRTS) Earns "Buy" Rating from HC WainwrightHC Wainwright reissued a "buy" rating and issued a $9.00 price target on shares of Alpha Tau Medical in a research note on Thursday.May 16, 2024 | marketbeat.comAlpha Tau Announces Alpha DaRT Treatment of First Patient with Liver Metastases of Colorectal CancerMay 13, 2024 | globenewswire.comAlpha Tau Presents Preclinical Data Demonstrating Abscopal Immune Effect in Pancreatic Murine Tumor Models at ESTRO 2024 Congress in GlasgowMay 6, 2024 | globenewswire.comAlpha Tau to Participate in May Investor ConferencesMay 1, 2024 | globenewswire.comAlpha Tau Medical Ltd. (NASDAQ:DRTS) Sees Large Increase in Short InterestAlpha Tau Medical Ltd. (NASDAQ:DRTS - Get Free Report) was the recipient of a large growth in short interest in the month of March. As of March 15th, there was short interest totalling 34,900 shares, a growth of 22.5% from the February 29th total of 28,500 shares. Approximately 0.1% of the company's stock are short sold. Based on an average daily volume of 34,500 shares, the days-to-cover ratio is currently 1.0 days.March 31, 2024 | marketbeat.comAlpha Tau to Present at the Jefferies Radiopharma Innovation SummitMarch 25, 2024 | globenewswire.comAlpha Tau Medical Ltd. Expected to Earn FY2024 Earnings of ($0.49) Per Share (NASDAQ:DRTS)Alpha Tau Medical Ltd. (NASDAQ:DRTS - Free Report) - Equities researchers at HC Wainwright lifted their FY2024 earnings per share estimates for shares of Alpha Tau Medical in a research report issued on Tuesday, March 12th. HC Wainwright analyst Y. Chen now expects that the company will post earnMarch 15, 2024 | marketbeat.comBuy Rating Affirmed: Anticipating Alpha Tau Medical’s Clinical Milestones and Growth Potential in 2024March 12, 2024 | markets.businessinsider.comAlpha Tau Medical Announces Full Year 2023 Financial Results and Provides Corporate UpdateMarch 7, 2024 | globenewswire.comAlpha Tau to Participate in Barclays 26th Annual Global Healthcare ConferenceFebruary 26, 2024 | globenewswire.comAlpha Tau Medical Stock (NASDAQ:DRTS), Quotes and News SummaryJanuary 8, 2024 | benzinga.comAlpha Tau to Present at the 42nd Annual J.P. Morgan Healthcare ConferenceDecember 20, 2023 | finance.yahoo.comAlpha Tau Medical Ltd. (NASDAQ:DRTS) Short Interest Up 12.9% in NovemberAlpha Tau Medical Ltd. (NASDAQ:DRTS - Get Free Report) was the target of a large growth in short interest during the month of November. As of November 30th, there was short interest totalling 73,500 shares, a growth of 12.9% from the November 15th total of 65,100 shares. Approximately 0.2% of the shares of the stock are sold short. Based on an average trading volume of 25,700 shares, the days-to-cover ratio is presently 2.9 days.December 16, 2023 | marketbeat.comAlpha Tau Medical (NASDAQ:DRTS) Now Covered by Analysts at CitigroupCitigroup assumed coverage on shares of Alpha Tau Medical in a report on Friday. They issued a "buy" rating and a $8.00 target price on the stock.December 15, 2023 | marketbeat.comAlpha Tau Announces Highly Promising Interim Results from Safety and Feasibility Trial of Alpha DaRT Treatment of Advanced Pancreatic CancerNovember 28, 2023 | finance.yahoo.comAlpha Tau Submits to Japanese PMDA for Pre-Market Approval of Alpha DaRT in Patients with Recurrent Head and Neck CancerNovember 20, 2023 | finance.yahoo.comAnalyst Ratings for Alpha Tau MedicalNovember 17, 2023 | markets.businessinsider.comAlpha Tau Medical GAAP EPS of $0.31November 16, 2023 | msn.com Get Alpha Tau Medical News Delivered to You Automatically Sign up to receive the latest news and ratings for DRTS and its competitors with MarketBeat's FREE daily newsletter. Email Address I was wrong. Dead wrong. (Ad)I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again. Here’s the full story for you. DRTS Media Mentions By Week DRTS Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. DRTS News Sentiment▼0.670.49▲Average Medical News Sentiment DRTS News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. DRTS Articles This Week▼20▲DRTS Articles Average Week Get Alpha Tau Medical News Delivered to You Automatically Sign up to receive the latest news and ratings for DRTS and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies AXGN News SIBN News TMCI News SMLR News TCMD News ZIMV News CVRX News NNOX News RCEL News SMTI News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:DRTS) was last updated on 11/23/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredBut another coin could soar even higher …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin co...Weiss Ratings | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | Sponsored24/7 Automated Profits in CryptoThe 4th quarter of 2024 is shaping up to be one of the most explosive periods for crypto in recent memory. But...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Alpha Tau Medical Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Alpha Tau Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free DRTS Stock Alerts